Back to Journals » OncoTargets and Therapy » Volume 6

Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation

Total article views   Abstract views HTML views PDF downloads Totals
9,059 Dovepress* 7,493 548+ 1,771 8,041
PubMed Central* 9 1,009 434 1,018
Totals 7,502 1,557 2,205 9,059
*Since 1 July 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 1 0 0 0 2

View citations on PubMed Central and Google Scholar